Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection.

Therapeutic and preventive treatment of mice intranasally infected with a lethal dose of A/Aichi/2/68 (H3N2) influenza virus with anaferon (pediatric formulation) demonstrated an antiviral effect of the drug (increased percent of survivors and prolonged lifespan).

[Reactogenicity, safety and immunogenicity of a recombinant bivaccine against smallpox and hepatitis B in limited clinical trials]. / Reaktogennost', bezopasnost' i immunogennost' rekombinantnoi bivaktsiny protiv ospy i gepatita B v ogranichennykh klinicheskikh ispytaniiakh.

The reactogenicity of the embryonic live recombinant variola and hepatitis B bivaccine as tablets (Revax-BT) as well as its safety and immunogenicity were evaluated in clinical trials made in volunteers who had previously immunized or not with variola vaccine. A preliminary conclusion was made on a lack of side effects and drug safety in primary vaccination and been revaccination with low and high doses. Primary immunization of volunteers and as bivaccination with high doses stimulated the most pronounced immune response to the vaccine virus versus such effect observed in immunization of volunteers with low vaccine doses. Humoral immune response to HBs was observed in 75% of volunteers of both groups after as bivaccination. Such response was most pronounced in examinees immunized with low vaccine doses versus those who received high bivaccine doses. At the same time, no protective levels of humoral immunity response to HBs Ag were observed in volunteers first vaccinated.

[Some pathogenetic characteristics of influenza infection in white mice]. / Nekotorye patogeneticheskie kharakteristiki grippoznoi infektsii u belykh myshei.

Influenza virus strain A/Aichi/2/68 replicated only in the lungs, nasal cavity, and trachea after intranasal challenge of white mice weighing 14-16 g. Rapid accumulation of the virus was associated with a somewhat delayed accumulation of endogenous interferon in the lungs, the concentration of interferon gradually decreasing by the end of the disease. An appreciable accumulation of the virus in the nasal cavity was coupled with weak interferon induction in this organ. On the other hand, a high level of interferon in the blood was concomitant with the development of slight sporadic viraemia.

[Study of the treatment-prophylactic effect of immunomodulators in experimental infections, caused by Marburg, Ebola, and Venezuelan equine encephalitis viruses]. / Izuchenie lechebno-profilakticheskogo deistviia immunomoduliatorov pri éksperimental'nykh infektsiiakh, vyzvannykh virusami Marburg, Ebola i Venesuél'skogo éntsefalomielita loshadei]

Therapeutic and prophylactic effects of immunomodifiers ridostin, reaferon, and polyribonate used alone and in various combinations were assessed in experiments on guinea pigs infected with Venezuelan equine encephalomyelitis (VEE) (strain Trinidad), Marburg (strain Popp), and Ebola (M/C-8 variant of Zaire strain) viruses at doses 5 to 20 respiratory LD50 through the respiratory airways. Urgent prophylactic simultaneous intramuscular and intranasal administration of ridostin protected the animals infected with Marburg virus (p = 0.1) and prolonged their life span by 2.4 days (p = 0.15). In Ebola infection a combination of ridostin and reaferon appreciably prolonged the mean life span: by 2.9 days (p = 0.04). In VEE ridostin alone or in combination with reaferone appreciably increased the share of survivors; ridostin with reaferon and polyribonate notably prolonged the mean life span of infected animals. None of these drugs or combinations produced an appreciable therapeutic effect in any of the studied infections.